|
1) Wasson JH, Bubolz TA, Lu-Yao GL, et al. Transurethral resection of the prostate among medicare beneficiaries: 1984 to 1997. For the Patient Outcomes Research Team for Prostatic Disease. J Urol. 2000; 164: 1212-5
|
|
|
|
2) Yu X, Elliott SP, Wilt TJ, et al. Practice patterns in benign prostatic hyperplasia surgical therapy: the dramatic increase in minimally invasive technologies. J Urol. 2008; 180: 241-5
|
|
|
|
|
|
3) Kuntz RM. Laser treatment of benign prostatic hyperplasia. World J Urol. 2007; 25: 241-7
|
|
|
|
|
|
4) Shah HN, Sodha HS, Kharodawala SJ, et al. Influence of prostate size on the outcome of holmium laser enucleation of the prostate. BJU Int. 2008; 191: 1536-41
|
|
|
|
|
|
5) Seki N, Tatsugami K, Naito S. Holumium laser enucleation of the prostate: comparison of outcomes according to prostate size in 97 Japanese patients. Neurourol Urodyn. 2007; 21: 192-6
|
|
|
|
|
|
6) Araki M, Lam PV, Wong C. High-power potassium-titanyl-phosphate laser photoselective vaporization prostatectomy for symptomatic benign prostatic hyperplasia. J Endourol. 2008; 22: 1311-4
|
|
|
|
|
|
7) 桑原勝孝, 堀場優樹, 大槻英男, 他. 前立腺肥大症に対する光選択的前立腺蒸散術(PVP): 当院における初期150例の検討. Jpn J Endourol ESWL. 2007; 20: 282-6
|
|
|
|
|
8) Hori Y, Kuromatsu I, Sugimura Y. Photoselective vaporization of the prostate using high power (80W) KTP laser: one year follow up of the first 101 patients in Japan. Int J Urol. 2008; 15: 1067-71
|
|
|
|
|
|
9) Motoka DJ, Averch TD. Predictability of irritative symptoms following photosensitive laser vaporization of the prostate. Can J Urol. 2007; 14: 3710-4
|
|
|
|
|
|
10) Fu WJ, Gao JP, Hong BF, et al. Photosensitive laser vaporization prostatectomy for acute urinary retention in China. J Endourol. 2008; 22: 539-43
|
|
|
|
|
|
11) Pfitzenmaier J, Gilfrich C, Pritsch M, et al. Vaporization of prostates of ＞ or ＝ 80ml using a potassium-titanyl-phosphate laser: midterm-results and comparison with prostates of＜ 80ml. BJU Int. 2008; 102: 322-7
|
|
|
|
|
|
12) Seki N, Nomura H, Yamaguchi A, et al. Evaluation of the learning curve for photosensitive vaporization of the prostate over the course of 74 cases. J Endourol. 2008; 22: 1731- 5
|
|
|
|
|
|
13) Kavoussi PK, Hermans MR. Maintenance of erectile function after photosensitive vaporization of the prostate for obstructive benign prostatic hyperplasia. J Sex Med. 2008; 5: 2669-71
|
|
|
|
|
|
14) Tugcu V, Tasci AI, Sahin S, et al. Comparison of photoselective vaporization of the prostate and transurethral resection of the prostate: a prospective nonrandomized bicenter trial with 2-year follow-up. J Endourol. 2008; 22: 1519-25
|
|
|
|
|
|
15) Stafinski T, Menon D, Harris K, et al. Photosensitive vaporization of the prostate for the treatment of benign prostatic hyperplasia. Can Urol Assoc J. 2008; 2: 124-34
|
|
|
|
|
|
16) Spaliviero M, Araki M, Page JB, et al. Catheter-free 120W lithium triborate (LBO) laser photoselective vaporization prostatectomy (PVP) for benign prostatic hyperplasia (BPH). Lasers Surg Med. 2008; 40: 529-34
|
|
|
|
|
|
17) Spaliviero M, Araki M, Wong C. Short-term outcomes of Greenlight HPS laser photoselective vaporization prostatectomy (PVP) for benign prostatic hyperplasia (BPH). J Endourol. 2008; 22: 2341-7
|
|
|
|
|
|
18) Ruszat R, Seitz M, Wyler SF, et al. Prospective single-centre comparison of 120-W diode-pumped solid-state high-intensity system laser vaporization of the prostate and 200-W high-intensive diode-laser ablation of the prostate for treating benign prostatic hyperplasia. BJU Int. 2009: 104; 820-5
|
|
|
|
|
|
19) Leonardi R. Preliminary results on selective light vaporization with the side-firing 980 nm diode laser in benign prostatic hyperplasia: an ejaculation sparing technique. Prostate Cancer Prostatic Dis. 2009: 12; 277-80
|
|
|
|
|
|
20) Bach T, Herrmann TR, Ganzer R, et al. RevoLix vaporesection of the prostate: initial results of 54 patients with a 1-year follow-up. World J Urol. 2007; 25: 257-62
|
|
|
|
|
|
21) Xia SJ, Zhuo J, Sun XW, et al. Thulium laser versus standard transurethral resection of the prostate: a randomized prospective trial. Eur Urol. 2008; 53: 382-9
|
|
|
|
|
|
22) Fu WJ, Hong BF, Yang Y, et al. Vaporesection for managing benign prostatic hyperplasia using a 2-micron continuous-wave laser: a prospective trial with 1-year follow-up. BJU Int. 2009; 103: 352-6
|
|
|
|
|
|
23) Yoon CJ, Kim JY, Moon KH, et al. Transurethral resection of the prostate with a bipolar tissue management system compared to conventional monopolar resectoscope: one-year outcome. Yonsei Med J. 2006; 47: 715-20
|
|
|
|
|
|
24) Fung BTC, Li SK, Yu CF, et al. Prospective randomized controlled trial comparing plasmakinetic vaporesection and conventional transurethral resection of the prostate. Asian J Surg. 2005; 28: 24-8
|
|
|
|
|
|
25) 中川 健. 前立腺肥大症に対する新しい低侵襲治療: その現状と手術の実際 TUEB. Urology View. 2007; 5: 95-9
|
|
|
|
|
|
26) 磯谷周治, 熊本友香, 知名俊幸, 他. TUR in salineシステムを用いた経尿道的前立腺蒸散術(T. U. V. Pis)の経験. 日泌誌. 2009; 100; 95
|
|
|
|
|
|
27) Huidobro C, Larson B, Mynderse S, et al. Characterizing prostive RF treatments of the prostate for BPH with gadolinium-enhanced MRI. Scientific World Journal. 2009; 18: 10-6
|
|
|
|
|
|
28) Mynderse LA, Larson B, Huidobro C, et al. Characterizing TUNA ablative treatments of the prostate for benign hyperplasia with gadolinium-enhanced magnetic resonance imaging. J Endourol. 2007; 21: 1361-6
|
|
|
|
|
|
29) Mattiasson A, Wagrell L, Schelin S, et al. Five-year follow-up of feedback microwave thermotherapy versus TURP for clinical BPH: a prospective randomized muticenter study. Urology. 2007; 69: 96-7
|
|
|
|
|
|
30) Vesely S, Muller M, Knutson T, et al. Transurethral microwave thermotherapy of the prostate-evaluation with MRI and analysis of parameters relevant to outcome. Scand J Urol Nephrol. 2008; 42: 53-8
|
|
|
|
|
|
31) Kaye JD, Smith AD, Badlani GH, et al. High-energy transurethral theramotehrapy with CoreTherm approaches transurethral prostate resection in outcome efficacy: a meta-analysis. J Endourol. 2008; 22: 713-8
|
|
|
|
|
|
32) Bartoletti R, Cai T, Tinacci G, et al. Transperineal microwave thermoablation in patients with obstructive benign prostatic hyperplasia: a phase I clinical study with a new mini-choked microwave applicator. J Endourol. 2008; 22: 1509-17
|
|
|
|
|
|
33) Maria G, Brisinda G, Civello IM, et al. Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia: results of a randomized, placebo-controlled study. Urology. 2003; 62: 259-64
|
|
|
|
|
|
34) Silva J, Pinto R, Carvallho T, et al. Mechanisms of prostate atrophy after glandular botulinum neurotoxin type A injection: an experimental study in the rat. Eur Urol. 2008. 〔Epub ahead of print〕
|
|
|
|
|
|
35) Brinsinda G, Cadeddu F, Vanella S, et al. Relief by botulinum toxin of lower urinary tract symptoms owing to benign prostatic hyperplasia: early and long-term results. Urology. 2009; 73: 90-4
|
|
|
|
|